Thomson Reuters
    EN : JP : CN : KR : ES : PT   
 
 
 
Current Patents Gazette


 
Gazette is a rapid competitive intelligence service covering innovation in the pharmaceutical industry. It offers full coverage of new patents and applications published during the previous seven days, expertly classified, analysed and put into context to provide quick and easy access to those areas important to your work.

Each week Gazette covers key pharmaceutical patent documents from around the world, compiled from a wide range of sources. Of prime importance are the PCT (Patent Co-operation Treaty) applications, published every Thursday by the World Intellectual Property Organisation (WIPO). Core coverage also includes European and UK applications, alongside US PreGrant published applications and issued patents. Research Disclosures are also covered. A unique feature is the informal researched comments on selected UK initial "A0" applications, and all European granted patents with value-added content in our DOLPHIN database are listed.

FEATURES

In addition Current Patents Gazette provides you with:
  • Weekly highlights focusing on patent-related issues making the headlines, on noteworthy new applications, and on litigation and legislation affecting the industry.
  • Analysis and comments to indicate where all new inventions fit into the applicants' existing portfolios and innovation profiles.
  • The option of electronic or printed format to suit you. The Gazette can be supplied as printed copy, PDF file or in database format, with links to source documents in electronic versions

GAZETTE CLASSIFICATION

Current Patents Gazette is categorised into five broad sections, allowing you to see at a glance the applications you are most interested in:
(click on a section title to view a sample page)

Section A: New Compounds
Section A of the Gazette covers all new applications describing novel compounds and derivatives with pharmaceutical utility. An analysis of the invention is provided, including its origin and how it relates to established drug candidates or research work, putting the discovery into its true commercial context. Because these new compound applications are especially important, all cases within Section A are presented with accompanying images of the full front page text of the specification, in order to provide at a glance the chemical structure of each compound as well as the official abstract, names of inventors and technical details.

Section B: New Uses, Formulations & Methods of Treatment
As candidates progress into development they often become the subject of further innovation. The claim types vary considerably, and include such aspects as new methods of treatment and formulations, alongside ancillary technology not directly related to therapy, such as diagnostics. Analysis of these new use and formulation cases can offer insights into which compounds are progressing towards commercial exploitation, in which formulations and for which precise indications.

Section C: Chemical Processes and Combinatorial Technology
Advances in chemical technology are another good indicator of a company's development activity and such cases are covered in Section C. Study of these scale-up cases can point to pipeline candidates being prepared for clinical trials and ultimately commercial production.

Section D: Biotechnology
Biotechnology is the most rapidly expanding and sometimes most controversial area in the pharmaceutical industry today. The latest advances in transgenics and cloning, viruses, enzyme and polypeptide compounds and immunology are all presented in Section D. Collaborations between companies and non-industrial researchers are also highlighted to provide you with the cutting edge in competitive intelligence.

Section E: Devices and Equipment
Section E is the first of two device-orientated sections covering advances in mechanical technology linked to the pharmaceutical and biotech sectors. Applications relating to analytical and manufacturing apparatus are featured alongside drug delivery devices, packaging and developments in software related to patient administration and remote diagnosis.




 


 

Contacts
General Information
Tel: +44 20 7433 4000
Fax: +44 20 7433 4001
ts.custserv.emea
@thomson.com


Customer Support Helpdesk

Tel: +44 20 7433 4999
ts.support.emea
@thomson.com

Subscribe

Gazette News Highlights

View the Current Patents Gazette weekly highlights focusing on patent-related issues making the headlines

 
Disclaimer | Terms of Use
Privacy Policy | Copyright